In plain English
UnitedHealth Group Inc. offers health insurance and operates the Optum health‑services arm, which delivers care delivery, data analytics,…
Company stock · NYSE · USD
UnitedHealth Group Inc
$418.09
Today
−$6.89-1.62%
vs yesterday’s close
Live price
Themes
Price chart Pro
Company briefing
Plain English context — why the name shows up in the news, and what to watch next.
UnitedHealth Group Inc. offers health insurance and operates the Optum health‑services arm, which delivers care delivery, data analytics,…
Latest on this name
24 recent cards — open any for the full deeper dive.
Tesla shares closed at $386.47 on Wednesday.
UnitedHealth’s solid earnings beat and raised outlook lift the stock, but valuation concerns keep price targets conservative.
Hot September CPI and rising Treasury yields suggest the Fed may hike rates again, putting pressure on growth stocks while earnings beats give a temporary lift to ASML, AZZ, GME, and UNH.
UnitedHealth’s earnings beat and upside outlook reinforce its growth narrative, while Optum Health’s multi‑year margin plan underscores a strategic shift toward value‑based care and AI‑enabled services.
UnitedHealth sees Medicaid margins bottoming in 2026 and expects a rebound, while CMS ratings and $0 premium plans strengthen its Medicare Advantage position.
UnitedHealth’s raised earnings outlook boosts its weight in healthcare ETFs, prompting investors to reconsider exposure, especially in the more concentrated IHF versus the diversified XLV and VHT.
UnitedHealth’s Q3 2026 results and guidance reinforce a strong growth trajectory, with AI and Medicare initiatives driving future earnings.
UnitedHealth’s Q3 beat and 2026 guidance lift suggest the company’s cost‑control and pricing strategies are outperforming expectations, potentially raising its long‑term earnings outlook.
UnitedHealth’s better‑than‑expected Q3 results are propelling its shares higher in pre‑market trade.
The week’s earnings from five major Dow components—worth 25.74% of DIA—will be a key driver of market volatility and could reshape the ETF’s performance.
UnitedHealth’s upcoming earnings will decide if the stock can recover from its recent pullback and meet upbeat forecasts.
UnitedHealth faces a Texas probe over alleged bribery, care delays, and coverage denials that could trigger regulatory penalties and stock pressure.
Warren and Hawley are probing insurers for data on zero‑payout claims, spotlighting possible aggressive claims practices and consumer trust issues.
Premiums fall, but tighter networks may cost seniors more out‑of‑network, reshaping the Medicare Advantage landscape.
UnitedHealthcare’s 2027 Medicare plans offer $0 premiums and low out‑of‑pocket costs to a broad senior audience, positioning the company to capture more Medicare Advantage market share amid growing demand for affordable, integrated care.
UnitedHealthcare’s 2027 Medicare plans slash costs and broaden access, solidifying its leadership in the Medicare Advantage market.
A $100 stake in UnitedHealth Group 15 years ago would have grown to nearly $880 today, reflecting the company’s robust, market‑outperforming performance.
UnitedHealth is trimming its Optum Health unit through a TPG partnership to restore margins and streamline operations after a costly earnings dip.
TPG is eyeing a $5 billion sale of Lyric as software dealmaking recovers from AI‑related uncertainty.
CMS is shutting the door on $3.4 billion of Medicare fraud by banning 11 suppliers, underscoring a tougher stance on billing abuse.
A $100 stake in UnitedHealth Group 20 years ago would now be worth $763, reflecting a 10.72% annualized return that outpaces the market by 1.51%.
A Bank of America VP was killed in a random Times Square stabbing, prompting a review of executive security but leaving the bank’s stock largely unchanged.
UnitedHealth’s stock gains are driven by fresh institutional ownership, a strong earnings beat, and a raised 2026 outlook, positioning it favorably for both short‑term momentum and long‑term value.
A $100 stake in UnitedHealth Group 15 years ago would now be worth $838.81, reflecting a 15.19% annualized return that outpaces the market by 2.18%.
Company reports
No filings here yet
Official report cards for UNH will show up here when available.
Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.